Neuroimaging Biomarkers for Early Drug Development in Schizophrenia

Biological Psychiatry - Netherlands
doi 10.1016/j.biopsych.2013.08.025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Role of Neuroimaging Biomarker in Drug Discovery for Schizophrenia

Folia Pharmacologica Japonica
Pharmacology
2012English

Neuroimaging Biomarkers for Psychosis

Current Behavioral Neuroscience Reports
2015English

Genomic Biomarkers for a Binary Clinical Outcome in Early Drug Development Microarray Experiments

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2011English

Role of Neuroimaging in Analgesic Drug Development

Drugs in R and D
Pharmacology
2008English

Biomarkers in Oncology Drug Development

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection

Annual Review of Clinical Psychology
MedicineClinical PsychologyPsychiatryMental Health
2013English

Validation of Analytic Methods for Biomarkers Used in Drug Development

Clinical Cancer Research
Cancer ResearchOncology
2008English

Receptors and Related Drug Development for Schizophrenia: Research Advances

Pharmacy Information
2016English

Neuroimaging Evidence for the Deficit Subtype of Schizophrenia

JAMA Psychiatry
MedicinePsychiatryMental Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy